TWD 17.5
(-9.79%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 276.39 Million TWD | 1.87% |
2022 | 271.33 Million TWD | 652.25% |
2021 | 36.07 Million TWD | 4.65% |
2020 | 34.46 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 259.86 Million TWD | -19.51% |
2024 Q1 | 322.86 Million TWD | 16.81% |
2023 FY | 276.39 Million TWD | 1.87% |
2023 Q2 | 265.38 Million TWD | 2.68% |
2023 Q1 | 258.46 Million TWD | 0.0% |
2023 Q3 | 261.02 Million TWD | -1.64% |
2023 Q4 | 276.39 Million TWD | 5.89% |
2022 Q4 | - TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 52.629% |
Level Biotechnology Inc. | 273.2 Million TWD | -1.171% |
Sagittarius Life Science Corp | 137.82 Million TWD | -100.545% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | -39.969% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 79.184% |
VBI | 21.25 Million TWD | -1200.64% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | 11.892% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 46.294% |
Visgeneer Inc. | 185.6 Million TWD | -48.918% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 79.111% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 62.291% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -130.602% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 87.694% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -4076.473% |
Enimmune corporation | 173.46 Million TWD | -59.342% |
TaiRx, Inc. | 60.62 Million TWD | -355.916% |
CHO Pharma, Inc. | 110.83 Million TWD | -149.386% |
EirGenix Inc. | 1.14 Billion TWD | 75.862% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -146.827% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 46.062% |
Lin BioScience, Inc. | 167.73 Million TWD | -64.788% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -194.939% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -338.492% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | -121.6% |
Lukas Biomedical Inc. | 161.05 Million TWD | -71.614% |
RBC Bioscience Corporation | 513.08 Million TWD | 46.13% |
BiOptic Inc. | 170.56 Million TWD | -62.051% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -555.626% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -1088.557% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -930.84% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 71.641% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -3851.945% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -1202.172% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 24.959% |
Neith Corporation | 17.43 Million TWD | -1485.493% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -3367.122% |
NaviFUS Corp. | 53.4 Million TWD | -417.591% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 42.595% |
Sinew Pharma Inc. | 39.71 Million TWD | -595.974% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -376.23% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 24.165% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -21.391% |
AP Biosciences Inc | 106.65 Million TWD | -159.165% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 92.17% |
3D Global Biotech Inc. | 30.68 Million TWD | -800.88% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | -41.027% |
Intech Biopharm Corporation | 1.54 Billion TWD | 82.089% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 68.099% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -2879.722% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -395.223% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -18.647% |
TCI GENE Inc. | 155.54 Million TWD | -77.694% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -983.578% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -498.59% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 15.853% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -325.97% |
PharmaEngine, Inc. | 91 Million TWD | -203.715% |
Savior Lifetec Corporation | 457.95 Million TWD | 39.645% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -149.143% |
OBI Pharma, Inc. | 650.44 Million TWD | 57.506% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 29.276% |
Acepodia, Inc. | 384.47 Million TWD | 28.109% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -223.073% |